{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T04:11:05Z","timestamp":1741234265345,"version":"3.38.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ejphar.2011.05.063","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T04:05:50Z","timestamp":1307937950000},"page":"242-249","source":"Crossref","is-referenced-by-count":10,"title":["Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats \u2014 Possible involvement of activation of M1 muscarinic receptors"],"prefix":"10.1016","volume":"667","author":[{"given":"Shunsuke","family":"Maehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Satow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Hikichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.05.063_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0731-7085(01)00410-1","article-title":"Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography\/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients","volume":"26","author":"Aravagiri","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine a novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","article-title":"Tissue concentrations of clozapine and its metabolites in the rat","volume":"9","author":"Baldessarini","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/edrv-6-4-564","article-title":"Dopamine: a prolactin-inhibiting hormone","volume":"6","author":"Ben-Jonathan","year":"1985","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/mcne.2001.1042","article-title":"M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices","volume":"18","author":"Berkeley","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0155","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(25)11335-9","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0030","first-page":"107","article-title":"Motor and mental side-effects of clozapine","volume":"55","author":"Gerlach","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0035","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/S0893-133X(99)00123-2","article-title":"The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia","volume":"21","author":"Geyer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00044011-199816010-00005","article-title":"A kinetic model for simultaneous fit of clozapine and norclozapine concentrations in chronic schizophrenic patients during long-term treatment","volume":"16","author":"Guitton","year":"1998","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3565(24)39166-9","article-title":"Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex","volume":"294","author":"Jones","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.104.075887","article-title":"Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats","volume":"312","author":"Jones","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"Kapur","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0922-4106(93)90126-T","article-title":"Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists","volume":"245","author":"Kuoppamaki","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2007.05.004","article-title":"Pharmacology of N-desmethylclozapine","volume":"115","author":"Lameh","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0070","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.npp.1300768","article-title":"N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors","volume":"30","author":"Li","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pbb.2008.06.023","article-title":"Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia","volume":"91","author":"Maehara","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meltzer","year":"1991","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0085","first-page":"47","article-title":"An overview of the mechanism of action of clozapine","volume":"55","author":"Meltzer","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0090","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.npp.1301279","article-title":"Evaluation of N-desmethylclozapine as a potential antipsychotic\u2014preclinical studies","volume":"32","author":"Natesan","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00426713","article-title":"Scopolamine induced leaning failures in man","volume":"52","author":"Peterson","year":"1977","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0100","first-page":"145","article-title":"The effects of scopolamine on working memory in healthy young volunteers","volume":"96","author":"Rusted","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","article-title":"Update on clinical efficacy and side-effects of clozapine","volume":"17","author":"Safferman","year":"1991","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00008877-199512000-00010","article-title":"DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors","volume":"6","author":"Sipes","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3565(24)29291-0","article-title":"The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat","volume":"299","author":"Stanhope","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0120","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1073\/pnas.1835612100","article-title":"N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity","volume":"100","author":"Sur","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130050741","article-title":"Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats","volume":"140","author":"Swerdlow","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02246437","article-title":"Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs","volume":"122","author":"Varty","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(98)00072-4","article-title":"M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague\u2013Dawley and Wistar rats","volume":"20","author":"Varty","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":"Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder","volume":"159","author":"Volavka","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.05.063_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0924-977X(98)00036-4","article-title":"Distribution of clozapine and desmethylclozapine between blood and brain in rats","volume":"9","author":"Weigmann","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2011.05.063_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911006467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911006467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T03:57:09Z","timestamp":1741233429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911006467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":31,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0014299911006467"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.063","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}